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Abstract
Working memory capacity, a critical component of executive function, expands developmentally 
from childhood through adulthood. Anomalies in this developmental process are seen in 
individuals with autism spectrum disorder (ASD), schizophrenia and intellectual disabilities (ID), 
implicating this atypical process in the trajectory of developmental neuropsychiatric disorders. 
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However, the cellular and neuronal substrates underlying this process are not understood. 
Duplication and triplication of copy number variants (CNVs) of 22q11.2 are consistently and 
robustly associated with cognitive deficits of ASD and ID in humans, and overexpression of small 
22q11.2 segments recapitulates dimensional aspects of developmental neuropsychiatric disorders 
in mice. We capitalized on these two lines of evidence to delve into the cellular substrates for this 
atypical development of working memory. Using a region- and cell-type-selective gene expression 
approach, we demonstrated that copy number elevations of catechol-O-methyl-transferase 
(COMT) or Tbx1, two genes encoded in the two small 22q11.2 segments, in adult neural stem/
progenitor cells in the hippocampus prevents the developmental maturation of working memory 
capacity in mice. Moreover, copy number elevations of COMT or Tbx1 reduced the proliferation 
of adult neural stem/progenitor cells in a cell-autonomous manner in vitro and migration of their 
progenies in the hippocampus granular layer in vivo. Our data provide evidence for the novel 
hypothesis that copy number elevations of these 22q11.2 genes alter the developmental trajectory 
of working memory capacity via suboptimal adult neurogenesis in the hippocampus.
One of the fundamental questions in developmental neurobiology centers on the 
development of various cognitive functions and how such development derails in mental 
disorders. The capacity of many cognitive functions develops from childhood to 
adulthood(1–3). Both cognition and working memory start to deteriorate at adolescence and 
predicts the onset of later schizophrenia(4–10). The developmental maturation of working 
memory starts to lag during a period from adolescence to adulthood in individuals with 
ASD(11, 12). Working memory correlates to IQ(13–15) and is less developed, throughout 
development and in adulthood, in individuals with intellectual disabilities (ID)(16–19).
Duplication, triplication and hemizygous deletion of a few hundred kb to a few Mb, 
collectively termed copy number variants (CNVs), confer the most robust risk factors, to 
date, for developmental delays in cognitive function and developmental neuropsychiatric 
disorders(20–22). Carriers of a 1.5Mb to 3Mb duplication or triplication at human 
chromosome 22q11.2 exhibit high rates of developmental delays in cognitive capacities(23–
25) and ASD and ID(26). Duplication of this chromosomal locus is also enriched in 
individuals with ASD and ID(20–22). However, the precise genetic elements within 22q11.2 
responsible for atypical cognitive development remain elusive due to their large duplication 
sizes in humans.
Using mouse models with constitutive overexpression of small 22q11.2 segments(27, 28), 
we showed that an arrest in developmental maturation of working memory capacity is 
recapitulated by copy number elevation of a 190kb region, including human COMT, 
TXNRD2 and ARVCF(29). Moreover, constitutive copy number elevation of another 200kb 
22q11.2 segment, containing human SEPT5, GP1BB, TBX1 and GNB1L, resulted in 
impaired social behaviors and compulsively repetitive behaviors, the latter of which were 
attenuated by an antipsychotic drug, suggesting relevance of this chromosomal segment to 
developmental neuropsychiatric disorders(30).
Among these 22q11.2-encoded genes, a high activity single nucleotide polymorphism (SNP) 
of COMT is associated with poor working memory after, but not before, 10 years of age, 
compared with a low activity COMT allele in humans (31). Moreover, a gain-of-function 
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mutation of TBX1 has been identified in individuals with developmental delays in cognition 
(32, 33). Over-expression of no other 22q11.2 genes has been shown to impair working 
memory. However, mutation carriers also have other CNVs and mutations (20, 34) and the 
impacts of SNPs are often inconsistent, presumably due to their weak effect sizes (35) in 
humans. While Comt and Tbx1 contribute to working memory and other ASD-related 
behavioral phenotypes in mice (36–38), the precise neuronal and cellular mechanisms 
through which elevated levels of these genes contribute to developmental working memory 
maturation are not known in humans or mice.
The targeted cell type and developmental time points are justified for four reasons. First, 
excitotoxic lesions of the hippocampal dentate gyrus damage adult neural stem/progenitor 
cells as well as mature neurons, and impair working memory in mice (Supplementary 
Results 1 and Supplementary Fig. 1a–c). Second, adult neural stem/progenitor cells have 
been functionally implicated in working memory in mice (39–41). Third, adult neural stem/
progenitor cells in the hippocampus express both Tbx1(36) and COMT (Supplementary 
Results 2 and Supplementary Fig. 2) in mice. As there is no reliable means to evaluate the 
proliferation and migration of adult neural progenitor cells in the brains of human carriers of 
22q11.2 copy number elevation, we examined the mechanisms through which high gene 
doses of the two 22q11.2 genes COMT and Tbx1 affect adult neurogenesis in mouse and 
cell models. Fourth, constitutive overexpression of a 190kb 22q11.2 segment, including 
COMT, attenuates working memory capacity at 2 months, but not at 1 month of age(29); 
these mouse ages correspond to adulthood and periadolescence, respectively(42). A similar 
phenomenon was observed from childhood to adulthood in humans who carry a high activity 
COMT allele (31).
Our data show that copy number elevations of the two 22q11.2 genes, COMT and Tbx1, in 
adult neural stem/progenitor cells of the hippocampus arrest the developmental maturation 
of working memory capacity and adult neurogenesis.
Materials and Methods
We used male C57BL/6J mice. We constructed lentiviral vectors carrying enhanced green 
fluorescence protein (EGFP), COMT-EGFP or Tbx1-EGFP, all under a murine stem cell 
virus promoter (MSCV), pseudotyped with vesicular stomatitis virus (VSV-G). These 
vectors achieved a high degree of selectivity to infect adult neural stem/progenitor cells 
(Supplementary Results 3 and Supplementary Figs. 3 and 4). The vectors were bilaterally 
infused into the dorsal hippocampus and mice were evaluated 7–10 days later at 1 month or 
2 months of age, in tasks designed to assess working memory, response to novelty, anxiety-
like behaviors and motor behavior(29). Cell types infected by the vectors were identified 
using flow cytometry and double fluorescence immunohistochemistry. The position of 
transduced cells was histochemically determined after completion of all behavioral tests. We 
examined the cell-autonomous effects of COMT or Tbx1 overexpression on proliferation 
and apoptosis of adult neural stem/progenitor cells of the hippocampus in cell culture (see 
Supplementary Information, Methods).
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Results
Copy number elevation of COMT and Tbx1 blunts the developmental expansion of working 
memory capacity
To examine the functional impact of COMT overexpression in adult neural stem/progenitor 
cells on the developmental trajectory of working memory, we infused the COMT vector 7–
10 days before 1 or 2 months of age, corresponding with before and after adolescence, 
respectively(42), and tested mice in a battery of behavioral assays (Fig. 1a).
Copy number elevation of COMT reduced working memory accuracy at 2 months of age, 
but not at age 1 month (Fig 1b). EGFP-infused mice showed 7, 10 and 13% higher rates of 
working memory at 0, 15 and 30 sec delays, respectively, at age 2 months compared to 1 
month (Fig. 1b inset), thereby recapitulating the developmental maturation of working 
memory capacity during this period in mice. In contrast, COMT-infused mice showed only 5 
and 1 % points higher and 13% points lower rates at 0, 15 and 30 sec delays, respectively, 
during the same developmental time span (Fig. 1b inset); working memory with a heavy 
load was more severely affected. COMT copy number elevation reduced time spent in the 
open arms of the elevated plus maze (Fig. 1d) and increased time spent in the margin area of 
the open field (Fig. 1e), indicative of heightened anxiety, at age 2 months, but not 1 month. 
In contrast, COMT copy number elevation had no effect on the exploration of a novel object 
(Fig. 1c) or motor activity in an inescapable open field(Fig. 1f).
We next tested the effects of copy number elevation of Tbx1 in adult neural stem/progenitor 
cells on working memory capacity at 1 and 2 months of age. Such treatment reduced 
working memory with a long delay at 2 months but not 1 month of age (Fig. 2a), but had no 
detectable effect on responses to a novel object (Fig. 2b), anxiety-like behavior in the 
elevated plus maze (Fig. 2c), and thigmotaxis (Fig. 2d) or locomotor activity (Fig. 2e).
Copy number elevation of COMT and Tbx1 arrests migration of adult neural stem/
progenitor cells
We examined the distribution of transduced cells after completing behavioral testing, when 
some newly-generated progenies of transduced adult neural stem/progenitor cells are 
expected to migrate into the granular layer from the subgranular zone. The majority of 
transduced cell bodies were located in and near the subgranular zone of the granular layer; 
their dendrites and axons reached the molecular layer of the dentate gyrus outward and 
extended toward the hilus and CA3 inward, respectively (Fig. 3a, b, c and d, upper images), 
a pattern consistent with that of maturing, migrating cells derived from adult neural stem/
progenitor cells.
The total number of cell counts is not suitable to evaluate the impact of COMT or Tbx1 on 
proliferation, as the numbers are affected by the uncontrollable extent of infused viral 
vectors in the hippocampus. We thus used the proportion of cell numbers among the three 
zones for analysis. This index is independent of the extent of initial random infection. Even 
if proliferation is additionally affected, the proportion would not change if the same 
proportion of cells migrate to mid and outer zones. Thus, the ratio is a selective index for 
evaluation of the migration process. Transduced cells were distributed with a clear gradient 
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from the subgranular/inner third zone to the outer third zone (see Fig. 3a, b, c and d, lower 
images). COMT-transduced cells remained in the subgranular/inner third zone more so at 
age 2 months than 1 month (Fig. 3a and b, bar graphs).
We observed the general gradient from the subgranular/inner third zone to the outer third 
zone in Tbx1-transduced cells at both 1 and 2 months of age. However, Tbx1-transduced 
cells remained more in the subgranular/inner third zone than EGFP-transduced cells at 2 
months of age (Fig. 3d, bar graphs), but we observed a more dispersed distribution of Tbx1-
transduced cells than EGFP-transduced cells at 1 month of age(Fig. 3c, bar graphs).
These data are consistent with our hypothesis that the migration of progenies of adult neural 
stem/progenitor cells is reduced by copy number elevation of COMT and Tbx1 in the 
hippocampal granular layer at 2 months of age, when these gene over-dosages impaired 
working memory.
Copy number elevation of COMT and Tbx1 arrests proliferation of adult neural stem/
progenitor cells
It is not possible to unequivocally evaluate how COMT and Tbx1 overexpression in adult 
neural stem/progenitor cells alone affects the proliferation and apoptosis of transduced cells 
in vivo. To determine the cell-autonomous effects of gene overexpression on proliferation 
and apoptosis, we isolated adult neural stem/progenitor cells and transfected them with a 
plasmid containing either EGFP, COMT-EGFP or Tbx1-EGFP (Fig. 4a). COMT copy 
number elevation significantly blunted and Tbx1 overexpression completely blocked the 
proliferation of adult neural stem/progenitor cells (Fig. 4b). The proportions of annexin+ 
cells were indistinguishable among the three groups (Fig. 4c), indicating that COMT and 
Tbx1 overexpression reduced the proliferation of adult neural stem/progenitor cells in a cell-
autonomous manner without altering apoptosis rate.
Discussion
Our data demonstrate that copy number elevations of the two 22q11.2 genes, COMT and 
Tbx1, in the hippocampal dentate gyrus reduced developmental maturation of working 
memory capacity and the proliferation – and migration of the progenies – of adult neural 
stem/progenitor cells. Whereas association between a COMT high activity allele and 
working memory deficits has been amply and elegantly demonstrated(43), our data show 
that overexpression of these two genes in adult neural stem/progenitor cells does not affect 
working memory per se, but the developmental expansion of its capacity from 1 to 2 months 
of age in mice.
COMT, but not Tbx1, over-expression in the adult, but not peri-adolescent, hippocampus 
exacerbated anxiety-related behaviors. This was a rather selective effect, as neither gene 
treatment altered novel response or motor activity. Ibotenic acid lesions severely impaired 
working memory, reduced response to a novel object and increased motor activity, but had 
no effect on anxiety-like behaviors (see Supplementary Fig.1c–g). While all the treatments 
equally reduced working memory capacity, these variable effects of COMT and Tbx1 
overexpression and excitotoxic lesions on other behaviors indicate that working memory 
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deficits cannot be adequately accounted for by the indirect effects of these treatments on the 
other behaviors.
We previously demonstrated that transgenic mice constitutively overexpressing a 190 kb 
human chromosomal 22q11.2 segment, including COMT,TNXRD2 and ARVCF, exhibited 
no maturation deficit of working memory in a no-delay version of spontaneous alternation at 
any age but showed deficits in working memory with delays in rewarded alternation at 2 
months but not at 1 month(29). Another report showed that the developmental maturation of 
working memory capacity is blunted from adolescence to adulthood in individuals with a 
high activity allele of COMT in humans(31). Our current data expand these mouse and 
human studies in three ways. First, we identified COMT and Tbx1 in hippocampal adult 
stem/neural progenitor cells as a functional contributor, although we do not rule out the 
possibility that mature neurons in the hippocampus and elsewhere are also involved. Second, 
working memory with delay, as measured by spontaneous alternation, was also affected by 
increased COMT dose. Third, working memory with delay is affected by Tbx1 
overexpression in the hippocampus at 2, but not 1, months of age.
Our data are unique in that specific contributory genes are identified but are consistent with 
studies that showed the detrimental impact of inhibition of adult stem/progenitor cells on 
working memory in rodents(39, 40). However, some aspects of our data are seemingly 
inconsistent with others. One study showed inhibition of adult neurogenesis did not impair 
working memory tasks where no delay is imposed in rats(44). However, in this study, rats 
did not show a robust delay-dependent performance reduction in the non-matching-to-place 
task in this study(44), raising the possibility that the task might not have been as sensitive to 
working memory load as our task. Our own data are consistent with this observation in that 
gene elevation of COMT and Tbx1 did not affect working memory with no delay as severely 
as working memory with delay (Figs. 1a and 2a)(29). The interval between inhibition of 
adult neurogenesis and testing of working memory is another parameter that could account 
for diverse results. Our mice were tested 7–10 days after gene over-expression. Other studies 
similarly showed that while working memory is severely impaired at 1 and 3 weeks after 
irradiation of adult stem cells(40), performance is normal at 7 weeks(40) and 4–8 weeks(44) 
or enhanced at 2.5 to 3 months(41) after inhibition of adult neurogenesis. Such normal 
performance might reflect a recovery of adult stem/progenitor cells or compensatory 
processes(40). Moreover, as it takes approximately 2 months for adult stem/progenitor cells 
to differentiate into mature neurons, stem cells or their immediate progenies (e.g., immature 
neurons) might mediate the detrimental effect of gene overdose in or functional inhibition of 
adult stem/progenitor cells. Taken together, these seemingly inconsistent data collectively 
suggest that working memory with a heavy load is more severely affected by a functional 
inhibition or reduction of adult stem/progenitor cells and their immediate progenies (i.e., 
immature neurons) than of mature neurons derived from adult stem/progenitor cells.
Overexpression of the protein products of these 22q11.2 genes might non-specifically reduce 
the functional capacity of adult stem cells in our mouse models and in human carriers of 
duplication and triplication. However, this possibility does not explain why the same gene 
overexpression did not affect working memory at 1 month of age. Certain intrinsic properties 
of adult neural stem/progenitor cells might underlie the age-dependent effect. There is a 
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drastic decline in the neurogenesis rate in the hippocampal subgranular zone from age 1 
month to 3 months in mice(45, 46) and from infancy to adulthood in humans(47–49). Given 
that COMT and Tbx1 overexpressing cells tended to remain at the inner third of the granular 
layer more so at age 2 months than 1 month, the endogenously diminished proliferation and 
migration at age 2 months might make it increasingly difficult for stem cells to overcome the 
detrimental effects of increased gene dose.
Not incompatible with this possibility, an additional potential mechanism is a developmental 
change in the properties of COMT and its substrates. Developmental maturation of working 
memory capacity from age 1 to 2 months occurred when endogenous COMT enhanced its 
capacity to methylate substrates in the hippocampus, presumably reflecting a higher activity 
ratio of membrane bound (MB)-COMT to soluble (S)-COMT at age 2 months, compared to 
1 month (Supplementary Results 4; Supplementary Fig 5 and Supplementary Table 1). 
Catecholamine depletion reduces the proliferation rate of adult neural stem/progenitor cells 
in the rodent subgranular zone under certain conditions(50, 51). As COMT also methylates 
any protein that contains catechol, catecholamines and other catechol-carrying molecules 
could serve as functional substrates for this age-dependent effect of COMT.
There might even be a distinct mechanism through which Tbx1 over-expression did not 
impair working memory at 1 month of age. Our data suggest that Tbx1 overexpressed at 1 
month facilitated migration, compared to EGFP; Tbx1 overexpression at 2 months induced 
the opposite pattern. It could be that newly generated cells at 1 month might have 
compensated for the impact of Tbx1 by facilitating migration of transduced cells due to their 
more active proliferation capacity, thus less detrimental effect on working memory.
One unique property of our study is that we evaluated the impact of gene overexpression on 
working memory and other behaviors following a 7–10 day recovery period after surgical 
gene transduction. Some newly-dividing cells can start to differentiate into neuroblasts 
within a few days and into neurons after a few weeks in the adult mouse brain, although it 
takes more than one week for differentiation into astrocytes(46). However, this time period is 
not sufficient for the majority of nascent neurons to mature to extend their axons to target 
neurons in the hilus and CA3(52) and their dendrites to express spines(53). Thus, the impact 
of cells newly generated from transduced stem cells during adulthood would be expected to 
remain relatively localized under our experimental protocol. As immature and maturing 
neurons bear a slow excitatory response to GABA inputs, COMT and Tbx1 overexpression 
might impair working memory by such local effects within the granular layer. A future 
challenge is to identify a novel substrate through which CNVs impact working memory by 
altering local electrophysiologic properties of newly-generated immature neurons at the time 
when mice exhibit blunted working memory capacity.
Molecules and their associated cascades in neonatal and adult neural stem/progenitor cells 
can be further exploited to better understand the developmental trajectories of cognitive and 
affective anomalies associated with ASD, ID and schizophrenia(37, 54). The ultimate 
validation of our observations in mouse and cell models will be achieved only when it is 
shown that potential therapies developed from such hypothetical mechanisms provide 
beneficial effects on the atypical developmental maturation of working memory in humans.
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Fig. 1. 
a. Experimental procedure. Upper and lower arrows indicate the time of surgical viral 
infusion and animal sacrifice for histological analysis, respectively. Thick horizontal lines 
indicate the time of behavioral assays. b. Percentage of alternations (means ± standard error 
of the mean (SEM)), an index of working memory, in a T-maze (Age × Treatment, 
F(1,55)=5.45, p=0.0232; Treatment × Delay, F(2,110)=3.64, p=0.0294). EGFP-infused mice 
performed better at 2 months than at 1 month of age (Age, F(1,24)=6.20, p=0.0201), but not 
COMT-infused mice (Age, F(1,31)=0.126, p=0.7245). COMT overexpression impaired 
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performance at all delays at 2 months (Treatment, F(1,33)=15.32, p=0.0004; Treatment × 
Delay, F(2,66)=1.64, p=0.2019; see ** at bracket), but not 1 month of age (Treatment, 
F(1,22)=1.38, p=0.2525). The dashed line indicates 50% (i.e., chance level). Inset: % change 
(%= (2 month/1 month) × 100). The dashed line indicates no change from age 1 to 2 
months. c. Time spent (means ± SEM) in novel object approach. COMT overexpression had 
no effect on performance (Treatment, F(1,45)=0.88, p=0.3537). d. Percentage of time 
(means ± SEM) spent in the open arms of the elevated plus maze. COMT overexpression 
obliterated increase in time from age 1 to 2 months spent in the open arms, indicative of a 
reduction in anxiety-like behavior (Age × Treatment, F (1,43)=4.11, p=0.049).* indicates a 
significant (5%) difference between EGFP and COMT groups of 2-month old mice, as 
determined by Newman-Keuls post-hoc comparison. e. Thigmotaxis, as time (means ± 
SEM) spent in the margin area of an inescapable open field. Control mice spent less time in 
the margin (i.e., a reduction in anxiety-like behavior) at age 2 months, compared to 1 month, 
but COMT-expressing mice did not (Age × Treatment, F (1,55 =9.55, p=0.0031). * indicates 
significantly (5%) different time points between EGFP and COMT groups of 2-month old 
mice, as determined by Newman-Keuls post-hoc comparison. f. Motor activity, as 
determined by horizontal distance traveled (means ± SEM), is not altered by COMT 
overexpression (Treatment, F (1,55)=0.83, p=0.3653). 1 month: EGFP, n=12; COMT-EGFP, 
n=12. 2 months: EGFP, n=14; COMT-EGFP, n=21. *, p<0.05; **, p<0.01.
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Fig. 2. 
Effects of Tbx1 overexpression on behaviors at age 1 and 2 months. a. Percentage of 
alternations (means ± SEM) in a T-maze. Tbx1 overexpression decreased working memory 
(Treatment, F(1,36)=5.80, p=0.021). Interaction of Age × Delay was significant 
(F(2,72)=11.99, p<0.0001), and exploratory ANOVA applied within each age indicated 
Treatment was significant at 2 months (F(1,23)=6.967, p=0.015; Treatment × Delay, 
F(2,46)=0.531, p=0.592), but not at 1 month (F(1,13)=1.68, p=0.218). Inset: % change (%= 
(2 month/1 month) × 100). b. Novel object approach (means ± SEM). Tbx1 overexpression 
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had no effect (Treatment, F(1,36)=0.055, p=0.817). c. Elevated plus maze. Tbx1 
overexpression had no effect on the relative time (means ± SEM) spent in the open arms of 
the maze (Treatment, F(1,36)=1.85, p=0.182; Treatment × Age, F(1,36)=2.19, p=0.147). d. 
Tbx1 overexpression had no effect on thigmotaxis (Treatment, F (1,36)=0.181, p=0.673; 
Treatment × Age, F(1,36)=0.04, p=0.848; Treatment × Age × Time F(5,180)=0.803, 
p=0.549). e. Tbx1 overexpression had no effect on motor activity (means ± SEM) 
(Treatment, F (1,36)=1.67, p=0.205). 1 month, EGFP, n = 8; Tbx1-EGFP, n = 7. 2 months, 
EGFP, n = 12; Tbx1-EGFP, n = 13.
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Fig. 3. 
Effects of COMT and Tbx1 overexpression on the localization of transduced cells in the 
hippocampal granular layer. The inner third zone includes the subgranular zone. Proportions 
(means ± SEM) of transduced cells are shown below representative images of COMT groups 
at 1 (a) and 2 months of age (b). More cells remained in the inner third zone following 
COMT overexpression at age 2 months than 1 month (Treatment, F(1,12584)=65.89, p< 
0.0001; Age, F(1,12584)=10.24, p=0.0014). 1 month group: EGFP, N=42 section images; 
COMT-EGFP, N=34 section images; 2 months group: EGFP, N=35 section images; COMT-
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EGFP, N=31 section images. Proportions (means ± SEM) of transduced cells in EGFP and 
Tbx1-EGFP injected groups at 1 month (c) and 2 months of age (d) are shown. The 
distribution of transduced cells was dependent on age and treatment. Relatively more cells 
were found in the inner zone than middle and outer cell zones of both EGFP-infused mice 
and Tbx-1 infused mice in an age-dependent manner (Treatment × Age, F(1,8962)=46.16, 
p<0.0001). 1 month group: EGFP, N=42 section images; Tbx1-EGFP, N=29 section images; 
2 months group: EGFP, N= 13 section images; Tbx1-EGFP, N=22 section images. 
Abbreviations: O, outer third zone; M, middle third zone: I, inner third zone; Isgz, inner, 
subgranular zone; Mol, molecular zone of the dentate gyrus; Gl, Granular layer of the 
dentate gyrus; CA3, Region III of hippocampus proper.
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Fig. 4. 
a. In vitro experimental design. b. Gene overexpression had differential effects on adult 
neural stem/progenitor cell proliferation (Gene × Day, F (2,66)=5.89, p=0.0044). Means (± 
SEM) are shown. ** beside brackets indicates significantly (1%) different from EGFP group 
at day 3 group; * and ** above symbols indicates significantly (5% and 1%, respectively) 
different from Day 0. N = 12 cell clones derived from 12 different pups/gene groups. c. 
Tbx1 and COMT overexpression had no effect on apoptosis of adult neural stem/progenitor 
cells in vitro (p=0.764). N=4 cell clones per gene group derived from 4 pups. Abbreviations: 
EGF, epidermal growth factor; G418, the antibiotic Geneticin.
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